1. King H, Aubert RE and Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-1431.
2. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047–1053.
3. Wong E, Backholer K, Harding J, Gearon E, Stevenson C, Freak-Poli R and Peeters A: A systematic review and meta-analysis of diabetes and risk of physical disability and functional impairment - protocol. Systematic Reviews 2012; 1-47.
4. Letchuman GR, Wan Nazaimoon WM, Wan Mohamad WB, Chandran LR, Tee GH, Jamaiyah H, Isa MR, Zanariah H, Fatanah I, Ahmad Faudzi Y: Prevalence of Diabetes in the Malaysian National Health Morbidity Survey III 2006. Medical Journal of Malaysia 2010; 65: 180-186.
5. Nabilla S. Direct costs of diabetes in an outpatient setting in Malaysia. National Committee for Clinical Research 2003, 2: 19-27.
6. Mafauzy M. Diabetes mellitus in Malaysia. Medical Journal of Malaysia 2006, 61: 397-398.
Research Article CODEN: IJPRNK ISSN: 2277-8713
Prabhu M, IJPRBS, 2015; Volume 4(1): 1-12 IJPRBS
Available Online at www.ijprbs.com
10
7. Mafauzy M. Diabetes control and complications in private primary health care in Malaysia. Medical Journal of Malaysia 2005; 60: 212-217.
8. Ismail M, Chee S, Nawawi H, Yusoff K, Lim T and James W. Obesity in Malaysia. Obesity Reviews 2002; 3: 203-208.
9. Donald A: What is Quality of Life? Hayward Medical Communication 2010, 1.
10. Maddigan SL, Feeny DH, Johnson JA: Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Quality of Life Research 2005; 14:1311-1320.
11. Saito, I. Inami, F. Ikebe, T. Moriwaki, C. Tsubakimoto, A. Yonemasu, K. (2006) Impact of Diabetes on Health-related Quality of Life in a Population Study in Japan. Diabetes Research and Clinical Practice, 73(1), 51-57.
12. Saito I, Inami F, Ikebe T, Moriwaki C, Tsubakimoto A, Yonemasu K, Ozawa H. Impact of Diabetes on Health-related Quality of Life in a Population Study in Japan. Diabetes Research and Clinical Practice 2006; 73: 51-57.
13. Rubin RR and Peyrot M. Quality of Life and Diabetes. Diabetes/Metabolism Research and Reviews 1999; 15: 205-218.
14. Peyrot M, Rubin R, Lauritzen T, Snoek FJ, Matthews DR and Skovlun SE. Psychosocial Problems and Barriers to Improved Diabetes Management: Results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabetic Medicine 2005; 22: 1379-1385.
15. Hill-Briggs F, Gary TL, Baptiste-Roberts K and Brancati FL. Thirty-six-item Short Form Outcomes Following A Randomized Controlled Trial in Type 2 Diabetes. Diabetes Care 2005; 28: 443-444.
16. Bradley C and Speight B: Patient perceptions of diabetes and diabetes therapy: Assessing quality of life. Diabetes/Metabolism Research and Reviews 2002; 18: S64-S69..
17. Atak N and Arslan U: A Pilot Project to Develop and Assess a Health Education Programme for Type 2 Diabetes Mellitus Patients. Health Education Journal 2005; 64: 339-346.
18. Ramachandran A, Wan Ma RC and Snehalatha C: Diabetes in Asia. Lancet 2010; 375: 408-418.
19. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH and Hu FB: Diabetes in Asia: epidemiology, risk factors, and pathophysiology. The Journal of the American Medical Association 2009; 301: 2129-2140.
Research Article CODEN: IJPRNK ISSN: 2277-8713
Prabhu M, IJPRBS, 2015; Volume 4(1): 1-12 IJPRBS
Available Online at www.ijprbs.com
11
20. Lee JW, Brancati FL and Yeh HC: Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008. Diabetes Care 2011; 34: 353-357.
21. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ and Birmingham CL: Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). The American Journal of Clinical Nutrition 2007; 86: 353-359.
22. Raji A, Seely EW, Arky RA and Simonson DC: Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. The Journal of Clinical Endocrinology and Metabolism 2001; 86(11): 5366-5371.
23. Chandalia M, Abate N, Garg A, Stray-Gundersen J and Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. The Journal of Clinical Endocrinology and Metabolism 1999; 84: 2329-2335.
24. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P and Son HY: Epidemic obesity and type 2 diabetes in Asia. Lancet 2006; 368: 1681-1688.
25. Shelgikar KM, Hockaday TD and Yajnik CS. Central rather than generalized obesity is related to hyperglycaemia in Asian Indian subjects. Diabetic Medicine 1991; 8: 712-717.
26. Koppes LL, Dekker JM, Hendriks HF, Bouter LM and Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 2005; 28: 719-725.
27. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS and Curtis Ellison R: Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2954-2959.
28. Rimm EB, Chan J, Stampfer MJ, Colditz GA and Willett WC: Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. British Medical Journal 1995; 310: 555–559.
29. Sultana G, Kapur P, Aqil M, Alam MS and Pillai KK. Drug utilization of oral hypoglycemic agents in a university teaching hospital in India. Journal of Clinical Pharmacology and Therapeutics 2010; 35: 267–277.
Research Article CODEN: IJPRNK ISSN: 2277-8713
Prabhu M, IJPRBS, 2015; Volume 4(1): 1-12 IJPRBS
Available Online at www.ijprbs.com
12
30. Vengurlekar S, Shukla P, Patidar P, Bafna R and Jain S: Prescribing pattern of antidiabetic drugs in indore city hospital. Indian Journal of Pharmaceutical Sciences 2008; 70: 637-640.
31. Yurgin N, Secnik K and Lage MJ. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clinical Therapeutics 2007; 29: 316-325.
32. Johnson JA, Pohar SL, Secnik K, Yurgin N, Hirji Z: Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001. BMC Health Services Research 2006; 6: 159.
33. John LJ, Arifulla M, Sreedharan J, Muttappallymyalil J, DAS R, John J and Basha A: Age and gender-based utilisation pattern of antidiabetic drugs in Ajman, United Arab Emirates. Malaysian Journal of Pharmaceutical Sciences 2012; 10: 79-85.
34. Edelson GW and Sowers JR. Insulin resistance in hypertension: a focused review. The American Journal of the Medical Sciences 1993; 306: 345-347.
35. Sowers JR: Insulin resistance and hypertension. Mol Cell Endocrinol 1990; 74: C87-C89.
36. Dudzinska, M. Kurowska, M. Tarach, J. Chitryn, A. Barton. B. (2008) Social problems of diabetics. The influence of diabetes on patients’ daily, family and personal lives. Department of Endocrinology, 8(4): 150-156.
37. Anderson R, Grigsby A, Freedland K, Groot M, McGill J, Clouse R and Lustman P. Anxiety and poor glycemic control: a meta-analytic review of the literature. The International Journal of Psychiatry in Medicine 2002; 32: 235-247.
Thank you for copying data from http://www.arastirmax.com